Updated Overall Survival Data and Biomarker Results from Sintilimab ORIENT-11 Study in First-Line Nonsquamous Non-Small Cell Lung Cancer Published in the Journal of Thoracic Oncology

In addition, biomarker results from the trial provide important insights for patients with high major histocompatibility complex (MHC) class-II expression.